Preclinical and First-in-Human Study of a Compact Radionuclide Labeled Self-Assembly Nanomedicine for Chemo-Radio-Theranostics of Cancer
ACS Nano · 28.01.2025 · 19 (3) · 3953-3965
DOI: 10.1021/acsnano.4c18489 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 13.01.2025. Verfasst von Hehe Xiong und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory & Center for Molecular Imaging and Translational Medicine, …. Hauptthemen laut MEDLINE: Radioisotopes, Theranostic Nanomedicine, Radiopharmaceuticals, Camptothecin. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: National Medical Research Council, Ministry of Education - Singapore, China Postdoctoral Science Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory & Center for Molecular Imaging and Translational Medicine, National Innovation Platform for Industry-Education Integration in Vac…
- Department of Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Peking Union Medical College Hospital, Ch…
- Department of Diagnostic Radiology, Yong Loo Lin School of Medicine, National University of Singapore, 119074, Singapore.
- Nanomedicine Translational Research Program, NUS Center for Nanomedicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore.
- Theranostics Center of Excellence (TCE), Yong Loo Lin School of Medicine, National University of Singapore, 11 Biopolis Way, Helios, 138667, Singapore.
- Clinical Imaging Research Centre, Centre for Translational Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117599, Singapore.
ORCID-Profile: Zhaohui Zhu, Zijian Zhou, Xiaoyuan Chen, Jingjing Zhang
Förderung
- National Medical Research Council
- Ministry of Education - Singapore
- China Postdoctoral Science Foundation
- Natural Science Foundation of Fujian Province
- National Research Foundation Singapore
- Science, Technology and Innovation Commission of Shenzhen Municipality
- National University of Singapore
- National Natural Science Foundation of China
Zitieren
APA
Xiong, H., Wang, R., Zhang, H., Zhang, Q., Qin, Y., Du, C., Zhang, X., Ye, J., Shi, C., Shen, H., Zhu, Z., Zhou, Z., Chen, X., & Zhang, J. (2025). Preclinical and First-in-Human Study of a Compact Radionuclide Labeled Self-Assembly Nanomedicine for Chemo-Radio-Theranostics of Cancer. ACS Nano, 19(3), 3953-3965. https://doi.org/10.1021/acsnano.4c18489
Vancouver
Xiong H, Wang R, Zhang H, Zhang Q, Qin Y, Du C, et al. Preclinical and First-in-Human Study of a Compact Radionuclide Labeled Self-Assembly Nanomedicine for Chemo-Radio-Theranostics of Cancer. ACS Nano. 2025;19(3):3953-3965. doi:10.1021/acsnano.4c18489
BibTeX
@article{Xiong2025,
author = {Xiong, Hehe and Wang, Rongxi and Zhang, Heng and Zhang, Qianyu and Qin, Yatong and Du, Chao and Zhang, Xinyi and Ye, Jinmin and Shi, Changrong and Shen, Huaxiang and Zhu, Zhaohui and Zhou, Zijian and Chen, Xiaoyuan and Zhang, Jingjing},
title = {Preclinical and First-in-Human Study of a Compact Radionuclide Labeled Self-Assembly Nanomedicine for Chemo-Radio-Theranostics of Cancer},
journal = {ACS Nano},
year = {2025},
volume = {19},
number = {3},
pages = {3953--3965},
doi = {10.1021/acsnano.4c18489}
}
EUVIMED